Interviews and Video Capture in Patients With GM1 Gangliosidosis
Condition(s):GM1 GangliosidosisLast Updated:June 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):GM1 GangliosidosisLast Updated:June 8, 2023Completed
Condition(s):GM1 GangliosidosisLast Updated:June 9, 2023Terminated
Condition(s):GM1 GangliosidosisLast Updated:August 30, 2023Recruiting
Condition(s):Morquio B Disease; GM1 Gangliosidosis Type IIILast Updated:April 30, 2020Unknown status
Condition(s):GM1 Gangliosidosis; GM1 Gangliosidosis, Type I; GM1 Gangliosidosis, Type 2; Beta-Galactosidase-1 (GLB1) DeficiencyLast Updated:January 17, 2024Active, not recruiting
Condition(s):GM1 Gangliosidosis; GM2 Gangliosidosis; Gaucher Disease, Type 2; Tay-Sachs Disease; AB Variant Gangliosidosis GM2; Sandhoff DiseaseLast Updated:November 8, 2021Completed
Condition(s):Lysosomal Diseases; Gangliosidosis; GM1Last Updated:January 22, 2024Recruiting
Condition(s):GM1 Gangliosidosis; Sandhoff Disease; Tay-Sachs DiseaseLast Updated:October 18, 2023Active, not recruiting
Condition(s):GM1 Gangliosidoses; GM2 Gangliosidoses; Tay-Sachs Disease; Sandhoff DiseaseLast Updated:April 14, 2021Terminated
Condition(s):Tay-Sachs Disease; Sandhoff Disease; Late Onset Tay-Sachs Disease; GM1 Gangliosidosis; GM2 GangliosidosisLast Updated:March 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.